Polygenic Risk of Epilepsy and Poststroke Epilepsy
Our findings suggest that, like other forms of epilepsy, genetic predisposition plays an essential role in PSE. These results underscore the need for future studies to elucidate the mechanisms underlying PSE development and to identify novel therapeutic avenues.
Authors
- Jennifer A. Kim (ORCID: https://orcid.org/0000-0003-3072-6198)
- Rajarshi Mazumder (ORCID: https://orcid.org/0000-0002-0489-5089)
- Lauren Hachmann Sansing (ORCID: https://orcid.org/0000-0002-6898-1680)
- Emily J. Gilmore (ORCID: https://orcid.org/0000-0002-4659-6861)
- David S. Liebeskind (ORCID: https://orcid.org/0000-0002-5109-8736)
- Cyprien Rivier (ORCID: https://orcid.org/0000-0002-1148-1829)
- Johan Zelano (ORCID: https://orcid.org/0000-0001-9445-4545)
- Guido J. Falcone (ORCID: https://orcid.org/0000-0002-6407-0302)
- Adam de Havenon (ORCID: https://orcid.org/0000-0001-8178-8597)
- Kevin Navin Sheth (ORCID: https://orcid.org/0000-0003-2003-5473)
- Santiago Clocchiatti‐Tuozzo (ORCID: https://orcid.org/0000-0001-5377-434X)
- Nishant K. Mishra (ORCID: https://orcid.org/0000-0002-9327-3707)
- Shubham Misra (ORCID: https://orcid.org/0000-0002-4920-2573)
- Lawrence J. Hirsch (ORCID: https://orcid.org/0000-0002-6333-832X)
- Bradford B. Worrall (ORCID: https://orcid.org/0000-0001-9386-4091)
Institutions
- University of California, Los Angeles (US)
- VA Connecticut Research and Education Foundation (US)
- University of Virginia (US)
- University of Gothenburg (SE)
Publication Details
- Journal
- Stroke
- Published
- 2024-11-06
- DOI
- https://doi.org/10.1161/strokeaha.124.047459
- Citations
- 14
- Primary Topic
- Pharmacological Effects and Toxicity Studies
- Type
- article
- Field-Weighted Citation Impact
- 15.53
Funders
- Yale University
- GW Pharmaceuticals
- SK Life Science
- Eisai
- Novo Nordisk
- Sahlgrenska Universitetssjukhuset
- National Institutes of Health
- Genentech
- Fogarty International Center